Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 701 - 750 out of 6,875

Document Document Title
WO/2010/038167A1
The invention is directed to a class of compounds, including the pharmaceutically acceptable salts of the compounds, having the structure of Formula (I) : as defined in the specification. The invention is also directed to compositions co...  
WO/2010/032988A2
The present invention relates to a kojic acid metal complex derivative bonded with an amino acid. More specifically, the invention relates to a kojic acid metal complex derivative into which an amino acid is introduced, and a preparation...  
WO/2010/031813A1
The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts, to formulations and uses in the treatment of, interalia, metabolic disorders.  
WO/2010/031820A1
The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts, to formulations and uses in the treatment of metabolic disorders.  
WO/2010/031750A1
The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.  
WO/2009/124723A9
This invention relates to the field of biologically active compounds and specifically to novel aureothin derivatives, pharmaceutical compositions comprising these novel aureothin derivatives, methods for the production of the aureothin d...  
WO/2010/030395A2
The present invention provides a novel class of withanolides that have been isolated from W. somnifera under aeroponic conditions or produced semi-synthetically from withanolide natural products. The invention also provides pharmaceutica...  
WO/2010/027418A1
Described herein are C5-C6 annelated naphthopyrans that possess at least one electron-withdrawing group. The compounds possess desirable properties such as increased fading kinetics. Also described herein are new methods for synthesizing...  
WO/2010/022313A2
Provided are processes for the preparation of complexes that are useful in purifying compounds having an inhibitory effect on sodium-dependent glucose cotransporter SGLT. The processes can reduce the number of steps needed to obtain the ...  
WO/2010/010578A2
The present invention provides a scalable process for the preparation of Stilbenes by (i) condensing 3,5-dialkylbenzyl phosphonates with 4'-O-tetrahydropyranyl benzaldehyde to get 3,5-alkyl-4'-O-tetrahydropyranyl Stilbene (ii) deprotecti...  
WO/2010/007027A1
The present invention provides a compound of formula (I) said compound is inhibitor of MMP-12 and/or MMP-13, and thus can be employed for the treatment of a disorder or disease characterized by abnormal activity of MMP-12 and/or MMP- 13....  
WO/2010/001821A1
Disclosed are a compound represented by general formula (I) (wherein R1 and R2 each represents a hydrogen, a lower acyl, a lower alkoxycarbonyl or the like; R3 represents a lower alkyl, a halogenated lower alkyl, a cycloalkyl, a heterocy...  
WO/2010/000773A1
Compounds of formula (I), wherein the substituents are as defined in claim 1, are suitable for use as herbicides.  
WO/2009/156889A1
The invention relates to derivatives of a compound of formula I: wherein R1 to R7 and X1 to X7 are as defined herein The invention relates to the uses thereof for treating diseases, conditions and/or disorders mediated by kappa opioid re...  
WO/2009/158381A1
The present invention provides compounds according to Formula (I): or pharmaceutically acceptable salts, solvates, esters, prodrugs, tautomers, and isomers thereof, wherein: ring A, n, q, R1, R2, R3, R4, R5, R6, each R7, each R7A, and R8...  
WO/2009/157313A1
Disclosed is a liquid crystalline compound having excellent properties including highly negative dielectric anisotropy. Also disclosed is a liquid crystal composition which comprises the compound. Further disclosed is a liquid crystal ...  
WO/2009/154766A1
Disclosed are aspartic protease inhibitors represented by the following Formula: wherein R1 , R2, R3, R4, R5, R6, R7a, R7b and n are as defined herein, or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising...  
WO/2009/150094A1
Pyranone, thiopyranone and cyclohexenedione compounds of formula (I), which are suitable for use as herbicides.  
WO/2009/150095A1
Pesticidal compositions containing pyrandione, thiopyrandione and cyclohexanetrione compounds and methods of using them to combat and control pests such as insect, acarine, mollusc and nematode pests.  
WO/2009/150093A1
Pyrandione, thiopyrandione and cyclohexanetrione derivatives of formula (I), which are suitable for use as herbicides.  
WO/2009/148282A2
The present invention relates to a diaryl hepatonoid compound of chemical formula (1) having virus inhibitory activity; its pharmaceutically acceptable salts; its hydrates, solvates or prodrugs; and a pharmaceutical composition containin...  
WO/2009/139438A1
Disclosed is a process for producing an optically active carboxylic acid from a racemic carboxylic acid in a conventional production facility with high efficiency and at low cost. Specifically disclosed is a process for producing an opt...  
WO/2009/136534A1
Disclosed is a liquid crystalline compound having excellent characteristics such as large negative dielectric anisotropy. A liquid crystal composition using the compound and a liquid crystal display device are also disclosed. A compound ...  
WO/2009/132453A1
Methods and compounds effective in ameliorating conditions characterized by unwanted calcium channel activity, particularly unwanted N-type and/or T-type calcium channel activity are disclosed. Specifically, a series of compounds of subs...  
WO/2009/131246A1
This invention relates to a new sordarin derivative or a pharmaceutically acceptable salt thereof, which has antimicrobial activities (especially, antifungal activities), to process for preparation thereof, to a pharmaceutical compositio...  
WO/2009/129726A1
The present invention provides novel nitrones, their preparation and use. The novel compounds have the following formula: I The compounds of the present invention have strong antioxidative activity, and are thrombolytic. These compounds ...  
WO/2009/130192A1
A process of preparing a compound of formula (I) wherein R represents a linear or branched C5 alkyl group, as well as the use of such compounds in a fragrant and/or flavouring composition.  
WO/2009/124638A1
Disclosed are novel compounds of formula (I) in which X has the meaning indicated in claim 1. Said compounds are suitable as antidiabetics.  
WO/2009/121939A2
This invention relates to a compound of generic formula (I): (I) as well as a pharmaceutically acceptable salt thereof, a tautomer, optical isomer or a mixture of optical isomers in any proportion, in particular a mixture of enantiomers,...  
WO/2009/121245A1
Novel Fostriecin (or FST) derivatives represented by formula (I), the pharmaceutical compositions and preparation methods thereof. The pharmaceutical uses of these compounds, especially the use for the preparation of pharmaceutical compo...  
WO/2009/118168A1
The invention relates to compounds which have an affinity to the ยต-opioid receptor and ORL1 receptor, to processes for preparation thereof, to medicaments comprising these compounds and to the use of these compounds for producing medica...  
WO/2009/118538A2
The present invention relates to a novel carbohydrate lactone, functionalized aliphatic polyesters and copolymers formed therefrom, and processes for the preparation thereof from renewable resources.  
WO/2009/116657A1
A method for producing cycloalkanedicarboxylic acid monoester including, (A) a process for obtaining a compound represented by formula (2) by protecting any one of two compounds of carboxyl groups represented by formula (1) with a group ...  
WO/2009/110003A1
The present invention provides a flavonol compound and a bioactive extract/fraction from Ulmus wallichiana useful for the management or prevention or treatment of bone disorders. Said extract/fraction comprising marker compounds of gener...  
WO/2009/108272A1
Skin brightening compositions based on esters of 5-hydroxy-2-methyl-4H- pyran-4-one. Also disclosed are methods of making the compositions as well as methods of using the compositions.  
WO/2009/106552A2
The present invention relates to a class of compounds and to diagnostic compositions containing such compounds where the compounds are iodine containing compounds. More specifically the iodine containing compounds are chemical compounds ...  
WO/2009/104849A1
Disclosed are cis-2,6-disubstituted tetrahydropyran derivatives and a preparation method thereof. The tetrahydropyran derivatives can be prepared by Prins-reacting tetrahydropyran derivatives with homopargylicalcohol derivatives in the p...  
WO/2009/096455A1
Disclosed is a pharmaceutical composition which is useful as a therapeutic agent for fatty liver diseases. The pharmaceutical composition comprises (1S)-1,5-anhydro-1-[5-(azulen-2-ylmethyl)-2-hydroxyphenyl]-D -glucitol or a pharmaceutica...  
WO/2009/092702A2
The present invention relates to ((2S,4R)-4,6-dihydroxytetrahydro-2H-pyran-2-yl)methyl carboxylates and a process for the production thereof. Furthermore, the present invention relates to a process for the production of statins and in pa...  
WO/2009/089210A1
The present invention is directed to novel processes for the preparation of sulfamide derivatves, useful in the treatment of epilepsy and related disorders.  
WO/2009/080761A1
A compound of general formula (I) wherein A, Y, W, R1, R2, R3, R4, R5, and R6 take various meanings for use in the treatment of cancer.  
WO/2009/081892A1
Disclosed is a compound represented by the general formula (I) below which has a strong COMT inhibitory effect, or a pharmacologically acceptable salt thereof. Also disclosed are a pharmaceutical composition containing such a compound or...  
WO/2009/077186A1
The present invention relates to nonsteriodal progesterone receptor modulators of the general formula 1, the use of the progesterone receptor modulators for producing medicaments and also pharmaceutical compositions containing these comp...  
WO/2009/077677A2
The invention relates to novel polyspirane compounds used in the treatment of diseases involving parasites that belong to the phylum of apicomplexae, and to a method for preparing the same.  
WO/2009/078033A2
The present invention relates to a novel process for isolation and recovery of compounds such as biosynthetically produced simvastatin in either lactone form or in the form of its acid salt in high yield and purity, from microbial fermen...  
WO/2009/077550A1
The present invention relates to a method for producing cis-2-(2-methyl-prop-1-ene-yl)-4-methyl-tetrahydropyrane, comprising the catalytic hydration of 2-(2-methyl-prop-1-ene-yl)-4-methylene-tetrahydropyrane in the presence of hydrogen a...  
WO/2009/074314A1
Pyrandione, thiopyrandione and cyclohexanetrione compounds, which are suitable for use as herbicides.  
WO/2009/069589A1
Disclosed is 1-(2-(4-((2,3-dihydro(1,4)dioxino(2,3-c)pyridin-7-ylmethyl)a mino)piperidin-1-yl)ethyl)-7-fluoro-1,5-naphthyridin-2(1H)-o ne monohydrate, which has a strong antibacterial activity. The compound is highly safe and useful as a...  
WO/2009/064418A1
The present invention comprises a new class of compounds useful for the modulation of Beta-secretase enzyme activity and for the treatment of Beta-secretase mediated diseases, including Alzheimer's disease (AD) and related conditions. In...  
WO/2009/059996A1
This invention relates to a synthetic nutritional composition suitable for use in the prevention of secondary infections following a viral infection characterised by neuraminidase activitycomprising a sialylated oligosaccharide and N-ace...  

Matches 701 - 750 out of 6,875